Moody’s affirms Virginia Mason Medical Center’s ‘Baa2’ rating

Moody’s Investors Service has affirmed Seattle-based Virginia Mason Medical Center’s “Baa2” long-term and underlying revenue bond ratings, affecting $451 million of debt.

Advertisement

The rating affirmation is based on a number of factors, including VMMC’s unique and stable value proposition.

Challenges to the organization include a relatively high amount of debt and a history of variable and somewhat suppressed margins.

The rating outlook is stable, reflecting Moody’s view that despite challenges to operations in the short term, management is expected to be able to assist the organization and return margins to current levels.

More articles on finance:
The interplay between HIEs, credit ratings and hospital M&A
Arkansas governor petitioned to restore insurance coverage for 53k: 4 things to know
7 hospital CFOs in the headlines

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.